View More Recent Stories
-
Tactile Systems Technology, Inc. Reports Third Quarter 2018 Financial Results; Increases 2018 Outlook
-
Tactile Systems Technology, Inc. Reports Second Quarter 2018 Financial Results; Updates 2018 Outlook
-
Tactile Medical Acquires Intellectual Property Rights Related to Pneumatic Compression Device Technology
-
Tactile Systems Technology, Inc. Reports First Quarter 2018 Financial Results; Updates 2018 Outlook
-
Tactile Medical Launches Next-Generation Flexitouch System: Flexitouch Plus
-
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2017 Financial Results; Introduces 2018 Outlook
-
Tactile Systems Technology, Inc. (TCMD) Reports Prelim. Q4 & FY17 Revenue Ranges Above Consensus
-
Tactile Systems Technology, Inc. Reports Preliminary Full Year and Fourth Quarter 2017 Revenue Results
-
Tactile Systems Technology, Inc. Reports Third Quarter 2017 Financial Results; Updates 2017 Outlook
-
Tactile Systems Technology, Inc. (TCMD) Prices 3.3M Secondary at $33/Sh
-
Tactile Medical Announces Pricing of Secondary Offering of Common Stock
-
Tactile Systems Technology, Inc. (TCMD) to Offer 2.75M Shares
-
Tactile Medical Announces Secondary Offering of Common Stock
-
Tactile Systems Technology, Inc. Reports Second Quarter 2017 Financial Results; Updates 2017 Outlook
-
Tactile Medical Announces Appointment of Cheryl Pegus to Board of Directors
-
Tactile Systems Technology, Inc. (TCMD) Appoints Thomas O’Donnell, Jr. as CMO
-
Tactile Medical Appoints Dr. Thomas F. O’Donnell, Jr. as Chief Medical Officer
-
Tactile Systems Technology, Inc. (TCMD) Receives FDA 510(k) Clearance for Flexitouch Plus
-
Tactile Medical Receives FDA 510(k) Clearance for Flexitouch® Plus, with Improved Therapy for At-Home Lymphedema Treatment
-
Tactile Medical Launches First and Only Pneumatic Compression Device for At-Home Head and Neck Lymphedema Treatment in U.S.
-
Tactile Systems Technology, Inc. Reports First Quarter 2017 Financial Results; Updates 2017 Outlook
-
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results; Provides 2017 Outlook
-
Tactile Medical to Ring the Nasdaq Stock Market Opening Bell
-
Tactile Systems Technology, Inc. Reports Preliminary Full Year and Fourth Quarter 2016 Revenue Results
-
Tactile Systems Technology, Inc. Reports Third Quarter 2016 Financial Results and Updates Fiscal Year 2016 Outlook
-
Tactile Systems (TCMD) Announces FDA 510(k) Clearance for New Indication of At-Home Lymphedema Treatment
-
Tactile Medical Receives FDA 510(k) Clearance for New Indication of At-Home Lymphedema Treatment
-
Tactile Systems Technology, Inc. Reports Second Quarter 2016 Financial Results and Introduces Fiscal Year 2016 Outlook; Q2 Revenue Increased 34% Year-over-Year

